Pharmaceutical compositions comprising modified fucans and methods relating thereto

A method of inhibiting a fibrous adhesion in an animal comprising administering a therapeutically effective amount of a medical composition comprising a therapeutically effective amount of a fucan in combination with at least one pharmaceutically acceptable excipient, filler, carrier or diluent, wherein the fucan has a sulphate content between about 14 to 40% w/w;

• a total carbohydrate content between about 37 to 75% w/w;
• a fucose content as a percentage of total carbohydrate content of between about 31 to 71%;
• an acetyl content as a ratio of acetyl:fucose of between about 0 to 20% w/w;
• a protein content of about 0 to 12% w/w;
• an appearance of white, off-white, light yellow, light orange, light green or light brown;
• and when made up to a 0.1% w/v solution results in a solution with a pH of about 4 to 8.

A method of inhibiting a fibrous adhesion in an animal comprising administering a therapeutically effective amount of a composition comprising a therapeutically effective amount of a fucan in combination with at least one pharmaceutically acceptable excipient, filler, carrier or diluent, wherein the fucan has a sulphate content of between about 14 to 40% w/w;

• a total carbohydrate content of between about 37 to 75% w/w;
• a fucose content as a percentage of total carbohydrate content of between about 70 to 100%;
• an acetyl content as a ratio of acetyl:fucose of between about 0 to 20% w/w;
• a protein content of about 0 to 12% w/w;
• an appearance of white, off-white, light yellow, light orange, light green or light brown;
• and when made up to a 0.1% w/v solution results in a solution with a pH of about 4 to 8.